White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Permission to pause: making treatment breaks part of the cancer care conversation
August 5, 2026 | White Papers and Resources |
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
Brought to you by Cuttsy + Cuttsy
A seat at the table: what the EU HTA reforms really ask of patient involvement
July 24, 2026 | White Papers and Resources |
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at …
Brought to you by Cuttsy + Cuttsy
Why faster trials make participant understanding more important than ever
July 15, 2026 | White Papers and Resources |
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Brought to you by Cuttsy + Cuttsy
Older trial participants reject bad design, not technology
July 8, 2026 | White Papers and Resources |
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Brought to you by Cuttsy + Cuttsy
5 key takeaways from the Patient Centricity and Engagement Conference
July 2, 2026 | White Papers and Resources |
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
Brought to you by Cuttsy + Cuttsy
It’s time to stop calling adverse events ‘manageable’
June 29, 2026 | White Papers and Resources |
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Brought to you by Cuttsy + Cuttsy
The value: why localisation pays off across global trials
June 26, 2026 | White Papers and Resources |
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Brought to you by Cuttsy + Cuttsy
The solution: Good localisation doesn’t feel translated
June 18, 2026 | White Papers and Resources |
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every …
Brought to you by Cuttsy + Cuttsy
Healthcare information is becoming easier to access. Trust isn’t.
June 17, 2026 | White Papers and Resources |
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
Brought to you by Cuttsy + Cuttsy
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
June 17, 2026 | White Papers and Resources |
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Brought to you by Cuttsy + Cuttsy